Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Benjamin Landry currently holds 364,539 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin Landry has been a net seller of HCAT stock. They have purchased $0 and sold $249.7K worth of shares.
Benjamin Landry's most recent insider trade was on Jun 1, 2026, when they sold 13,779 shares at $1.37 per share.
Benjamin Landry serves as Executive at Health Catalyst, Inc. (HCAT). They have executed 22 insider transactions totaling $249.7K over their tenure at the company.
Benjamin Landry holds the position of Executive at Health Catalyst, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Benjamin Landry has shown a selling trading pattern, with $0 in total purchases and $249.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Benjamin Landry was on May 31, 2024, when they sold $83.1K worth of HCAT shares. This transaction involved 12,577 shares at $6.61 per share.
Benjamin Landry currently owns 364,539 shares of Health Catalyst, Inc. (HCAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Benjamin Landry's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Benjamin Landry has 22 Form 4 filings on record as an insider at Health Catalyst, Inc..
Set alerts for Benjamin Landry and 40,000+ other insiders.